Search Results - "Hass, H G"

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial by Nehls, O, Oettle, H, Hartmann, J T, Hofheinz, R-D, Hass, H G, Horger, M S, Koppenhöfer, U, Hochhaus, A, Stieler, J, Trojan, J, Gregor, M, Klump, B

“…This prospective multicentre phase II study characterises the toxicity and activity of first-line capecitabine and oxaliplatin combination therapy (CAPOX) in…”
Get full text

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX by NEHLS, O, OKECH, T, HARTMANN, J. T, PORSCHEN, R, GREGOR, M, KLUMP, B, HSIEH, C.-J, ENZINGER, T, SARBIA, M, BORCHARD, F, GRUENAGEL, H.-H, GACO, V, HASS, H. G, ARKENAU, H. T

“…We evaluated the expression patterns of proapoptotic BAX, antiapoptotic Bcl-2 and p53, the proposed upstream effector of these molecules, as potential…”
Get full text

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial by von Einem, J. C., Heinemann, V., von Weikersthal, L. Fischer, Vehling-Kaiser, U., Stauch, M., Hass, H. G., Decker, T., Klein, S., Held, S., Jung, A., Kirchner, T., Haas, M., Holch, J., Michl, M., Aubele, P., Boeck, S., Schulz, C., Giessen, C., Stintzing, S., Modest, D. P.

“…Purpose AIO KRK-0104 investigated first-line therapy of metastatic colorectal cancer (mCRC) with cetuximab, capecitabine and irinotecan versus cetuximab,…”
Get full text

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial by Nehls, O, Klump, B, Arkenau, H T, Hass, H G, Greschniok, A, Gregor, M, Porschen, R

“…We studied the activity of combined oxaliplatin and fluorouracil-leucovorin in 16 consecutive patients with advanced biliary tract adenocarcinomas. The disease…”
Get full text

Effects of a Phone-Based Follow-Up Care After Inpatient Rehabilitation for Breast Cancer Patients - A Randomized Controlled Trial by Hass, H G, Muthny, F, Stepien, J, Lerch, J, von der Marwitz, C, Schröck, R, Berger, D, Tripp, J

“…Benefit and long-term effects of rehabilitation and psychoeducational interventions after cancer therapy are still controversial discussed. Aim of the study…”
Get more information

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial by Stintzing, S, Fischer von Weikersthal, L, Vehling-Kaiser, U, Stauch, M, Hass, H G, Dietzfelbinger, H, Oruzio, D, Klein, S, Zellmann, K, Decker, T, Schulze, M, Abenhardt, W, Puchtler, G, Kappauf, H, Mittermüller, J, Haberl, C, Giessen, C, Moosmann, N, Heinemann, V

“…Background: The AIO KRK-0104 randomised phase II trial investigated the efficacy and safety of two capecitabine-based regimens: combination of capecitabine and…”
Get full text

Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva)--a case report by Hass, H G, Denzlinger, C

“…Hepatocellular carcinoma (HCC) is the 5th most common human malignancy with an increasing incidence in western countries and still unsatisfactory median…”
Get more information

Sarcoidosis mimicking cholangiocarcinoma by Nehls, O, Hass, H G, Weber, P, Dette, S, Lauer, U M, Schlemmer, H-P, Oehlert, M, Gregor, M, Klump, B

Get more information

A 56-year-old female patient with Raynaud's syndrome, increased liver enzymes and neuropsychiatric symptoms by Hass, H G, Kaiser, S

“…A 56-year-old woman presented with increased liver enzymes (GPT, GOT), arthralgias, Raynaud's syndrome and disturbance of sleep and concentration. Serology and…”
Get more information

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0I04 trial by STINTZING, S, VON WEIKERSTHAL, L. Fischer, SCHULZE, M, ABENHARDT, W, PUCHTLER, G, KAPPAUF, H, MITTERMÜLLER, J, HABERL, C, GIESSEN, C, MOOSMANN, N, HEINEMANN, V, VEHLING-KAISER, U, STAUCH, M, HASS, H. G, DIETZFELBINGER, H, ORUZIO, D, KLEIN, S, ZELLMANN, K, DECKER, T

Get full text

Randomized trial comparing cetuximab plus XELIRI versus cetuximab plus XELOX as first line treatment of patients with metastatic colorectal cancer (mCRC): A study of the german AIO CRC study group by Heinemann, V., von Weikersthal, L. Fischer, Vehling-Kaiser, U., Stauch, M., Oruzio, D., Schulze, M., Hass, H. G., Weiss, J., Dietzfelbinger, H., Moosmann, N.

“…Abstract only…”
Get full text

The gene coding for secreted phosphoprotein1/osteopontin is the most overexpressed gene in cholangiocarcinoma—detected by oligonucleotide arrays and LightCycler analysis by Hass, H. G., Jobst, J., Nehls, O., Frilling, A., Hartmann, J. T., Kaiser, S.

“…Abstract only 10036 Background: Cholangiocarcinomas (CCC) are the second most common primary hepatic malignancy with a still poor prognosis and arise from…”
Get full text

Major prognostic impact of proapoptotic BAX protein expression in stage III (UICC) colon cancer treated by adjuvant chemotherapy by Nehls, O., Okech, T., Hsieh, C.-J., Gaco, V., Hass, H. G., Sarbia, M., Borchard, F., Gruenagel, H.-H., Arkenau, H. T., Porschen, R., Klump, B.

“…Abstract only…”
Get full text

Treatment of chronic hepatitis C in naive patients with high-dose interferon-alpha2a induction therapy and two different ribavirin doses by Hass, H G, Nehls, O, Gregor, M, Kaiser, S, Kreysel, C

Get full text

Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS) by Hass, H G, Nägele, T, Seeger, U, Hösl, F, Gregor, M, Kaiser, S

“…Hepatic encephalopathy (HE) is a common problem in liver cirrhosis and is associated with typical changes of cerebral metabolite pattern observed by proton…”
Get more information

Krebs und Ernährung by Faber, G., Beinert, T., Hass, H.G., Lotze, C.

“…Zusammenfassung Tumorassoziierte Ernährungsprobleme werden meist auf die Entwicklung einer Kachexie im Verlauf schwerer Erkrankungen reduziert: Der erhöhte…”
Get full text